5Goldberg DS, McGee SJ. Pain as a global public health priority [ J ]. BMC Public Health,2011,6( 11 ) :770.
6Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC [ J ]. Lancet Oncology ,2012,13 ( 2 ) :e58-e68.
7Dworkin RH, Turk DC, Basch E, et al. Considerations for extrapola- ting evidence of acute and chronic pain analgesic efficacy [ J ]. Pain, 2011,152(8) :1705-1708.
8Holen JC, Lydersen S, Klepstad P,et al. The Brief Pain Inventory : pain' s interference with functions is different in cancer pain com- pared with noneancer chronic pain [ J ]. Clin J Pain, 2008,24 ( 3 ) : 219-225.
9Stjernsward J, Colleau SM, Ventafridda V. The World Health Or- ganization Cancer Pain and Palliative Care Program. Past, present, and future [ J ]. J Pain Symptom Manage, 1996,12 ( 2 ) :65 -72.
10U.S. Food and Drug Administration. Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) [ M ]. MD : Silver Spring,2013.
